Novo Integrated Sciences Return on Tangible Equity 2012-2024 | NVOS

Current and historical return on tangible equity values for Novo Integrated Sciences (NVOS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Novo Integrated Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-05-31 $-0.03B $-0.01B 769.23%
2024-02-29 $-0.01B $-0.00B -2400.00%
2023-11-30 $-0.01B $0.00B -1120.00%
2023-08-31 $-0.01B $0.00B inf%
2023-05-31 $-0.03B $0.00B 2133.33%
2023-02-28 $-0.04B $0.00B 2000.00%
2022-11-30 $-0.04B $-0.01B 2000.00%
2022-08-31 $-0.03B $-0.01B 13200.00%
2022-05-31 $-0.01B $0.00B -866.67%
2022-02-28 $-0.01B $0.00B -257.14%
2021-11-30 $-0.01B $0.00B -142.86%
2021-08-31 $-0.00B $0.00B -106.67%
2021-05-31 $-0.01B $0.01B -160.00%
2021-02-28 $-0.01B $0.00B -300.00%
2020-11-30 $-0.01B $0.00B -300.00%
2020-08-31 $-0.01B $0.00B -222.22%
2020-05-31 $-0.00B $0.00B -40.00%
2020-02-29 $-0.00B $0.00B -40.00%
2019-11-30 $0.00B $0.00B 0.00%
2019-08-31 $0.00B $0.00B 0.00%
2019-05-31 $0.00B $0.00B 0.00%
2019-02-28 $0.00B $0.00B 0.00%
2018-11-30 $-0.00B $0.00B inf%
2018-08-31 $-0.00B $0.00B 80.00%
2018-05-31 $-0.00B $0.00B 40.00%
2018-02-28 $-0.00B $0.00B 26.67%
2017-11-30 $0.00B $-0.01B 0.00%
2017-08-31 $0.00B $-0.01B 0.00%
2017-03-31 $0.00B $0.00B nan%
2017-02-28 $0.00B nan%
2016-11-30 $0.00B nan%
2016-09-30 $0.00B $0.00B nan%
2016-05-31 $0.00B nan%
2016-03-31 $0.00B $0.00B nan%
2015-06-30 $-0.00B $0.00B 800.00%
2015-03-31 $-0.00B $0.00B 400.00%
2014-06-30 $0.00B $-0.00B 0.00%
2014-03-31 $0.00B $-0.00B 0.00%
2013-09-30 $0.00B $-0.00B 0.00%
2013-06-30 $0.00B $-0.00B 0.00%
2012-12-31 $0.00B $-0.00B 0.00%
2012-09-30 $0.00B $-0.00B 0.00%
2012-03-31 $-0.00B $-0.00B 100.00%
2012-02-29 $-0.00B $0.00B 400.00%
2011-11-30 $-0.00B inf%
2011-09-30 $-0.00B inf%
2011-08-31 $-0.00B inf%
2011-06-30 $-0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.001B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.749B 11.95
Quest Diagnostics (DGX) United States $18.048B 18.29
DaVita (DVA) United States $12.959B 16.76
Encompass Health (EHC) United States $10.338B 24.37
Chemed (CHE) United States $8.511B 26.16
Elanco Animal Health (ELAN) United States $6.980B 16.61
RadNet (RDNT) United States $6.182B 137.03
Option Care Health (OPCH) United States $3.889B 18.43
Amedisys (AMED) United States $2.980B 21.21
LifeStance Health (LFST) United States $2.832B 0.00
Addus HomeCare (ADUS) United States $2.287B 26.84
Astrana Health (ASTH) United States $2.106B 33.01
U.S Physical Therapy (USPH) United States $1.390B 36.55
Pennant (PNTG) United States $1.156B 46.74
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Atai Life Sciences (ATAI) Germany $0.245B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.013B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00